ChemoTech releases its first animation explaining its latest R&D-project
Scandinavian ChemoTech AB is releasing a short animated video that explains its next R&D-project D-EEPC (Dynamic-ElectroEnhanced Pain Control™). This project can potentially become a revolutionary treatment for treating pain for patients with secondary bone cancer, especially located to the spine.
The film is published on our website www.chemotech.se and on our youtube channel with the link https://youtu.be/KgVQWYrKgio.
For further information, please contact:
Mohan Frick, CEO
Tele: +46 (0)10-218 93 03
Mail: info@chemotech.se
Scandinavian ChemoTech AB (publ)
ChemoTech is a young and dynamic life science company that possesses a great medical expertise and technical knowledge. Our latest launch of IQWave™ is an innovation within electrochemotherapy, that is adapted for the treatment of different types of tumors. ChemoTech strives to contribute to a more accessible cancer care. ChemoTech's shares (CMOTEC B) are listed on NASDAQ First North in Stockholm and Västra Hamnen Corporate Finance AB is the company's Certified Adviser. The company is headquartered in Malmö, in the midst of the medical technology expansionary Öresund region.
Tags: